Suano, Mcknzy .
HRN: 22-59-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2023
CEFUROXIME 750MG (VIAL)
02/19/2023
02/26/2023
IV
750 Mg
Q8
Age With Mod; T/C Amoebiasis, URTI
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes